Is DSGN or VREX more profitable?

VREX runs the higher net margin — DSGN at 0.00% versus VREX at 2.55%.

How have DSGN and VREX total returns compared?

Over the past 5 years, DSGN delivered -3.82% and VREX delivered -8.41% annualized total return. Past performance doesn't predict future results.

Design Therapeutics, Inc. (DSGN) vs Varex Imaging Corporation (VREX)

A side-by-side comparison of Design Therapeutics, Inc. and Varex Imaging Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DSGN

Design Therapeutics, Inc.

$748M

$11.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VREX

Varex Imaging Corporation

$778M

$18.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DSGN vs VREX

growth of $100 · dividends reinvested · last 6y

DSGN -70.1% (-18.2%/yr)VREX -12.1% (-2.1%/yr)VREX compounded faster over this window

DSGN VREX

DSGN vs VREX: by the numbers

•VREX is the larger company ($778M vs $748M market cap).
•VREX is profitable (2.55% net margin) while DSGN runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	DSGN	VREX
P/E ratio	N/A	35.24
Forward P/E	N/A	17.27
P/S ratio	N/A	0.90
P/B ratio	3.70	1.57
EV / EBITDA	N/A	10.58

Profitability

Metric	DSGN	VREX
Gross margin	0.00%	34.32%
Operating margin	0.00%	-3.29%
Net margin	0.00%	2.55%
ROE	-35.07%	4.45%
ROIC	-38.92%	6.30%

Growth (annualized)

Metric	DSGN	VREX
Revenue CAGR (5Y)	N/A	2.57%
Total return CAGR (5Y)	-3.82%	-8.41%

Frequently asked

Is DSGN or VREX more profitable?: VREX runs the higher net margin — DSGN at 0.00% versus VREX at 2.55%.
How have DSGN and VREX total returns compared?: Over the past 5 years, DSGN delivered -3.82% and VREX delivered -8.41% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DSGN analysis Full VREX analysis Interactive comparison tool

Dig into the metrics

Varex Imaging P/E ratio Design Therapeutics ROE Varex Imaging ROE Design Therapeutics operating margin Varex Imaging operating margin Design Therapeutics revenue growth Varex Imaging revenue growth Design Therapeutics free cash flow Varex Imaging free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.